Egrifta Prices, Coupons and Patient Assistance Programs
Egrifta (tesamorelin) is a member of the growth hormones drug class and is commonly used for Lipodystrophy.
The cost for Egrifta subcutaneous powder for injection 2 mg is around $7,323 for a supply of 30 powder for injection, depending on the pharmacy you visit. Quoted prices are for cash-paying customers and are not valid with insurance plans. This price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.
Subcutaneous Powder For Injection
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Egrifta Coupons, Copay Cards and Rebates
Egrifta offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional.
Drugs.com Printable Discount Card
The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.Print Free Discount Card
Note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.
Egrifta SV Co-Pay Assistance Program
Eligible commercially insured patients may pay as little as $0 co-pay; for additional information at 833-238-4372.
- Applies to:
- Egrifta SV
- Number of uses:
- Per prescription until program expires
Form more information phone: 833-238-4372 or Visit website
Patient Assistance & Copay Programs for Egrifta
Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.
No Patient Assistance Programs were found for this medication. However, your healthcare provider may have more information concerning specific programs available in your area.
More about Egrifta (tesamorelin)
- Check interactions
- Compare alternatives
- Reviews (16)
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: growth hormones
- En español